CRS

Carpenter Technology Corporation
$385.81
-1.29 (-0.33%)
Mkt Cap 19.17B
Volume 608,567
52W Range 233.78-625.99
Sector Basic Materials
Beta 1.29
EPS (TTM) 10.59 USD
P/E Ratio 36.43
Revenue (TTM) 3.12B USD
Rev Growth (5Y) +16.2%
EPS Growth (5Y) +30.1%
AlphaVal · Fair Value
What we estimate one share is worth
$73.08
Overvalued strong signal
428.0% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B-
Other Commodity Producers
65.3 / 100 composite
A commodity producer — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 3.12B 2.88B 2.76B 2.55B 1.84B 1.48B 2.18B 2.38B 2.16B 1.80B 1.81B 2.23B
Net Income 529.80M 376.00M 186.50M 56.40M (49.10M) (229.60M) 1.50M 167.00M 188.50M 47.00M 11.30M 58.70M
EPS 10.59 7.49 3.75 1.15 -1.01 -4.75 0.02 3.50 3.99 0.99 0.23 1.11
Free Cash Flow 362.30M 286.10M 178.30M (67.60M) (85.30M) 149.50M 60.40M 52.10M 74.20M 30.80M 161.70M 112.10M
FCF / Share 7.25 5.70 3.59 -1.39 -1.76 3.10 1.26 1.09 1.57 0.66 3.36 2.13
Operating CF 605.00M 440.40M 274.90M 14.70M 6.00M 250.00M 231.80M 232.40M 209.20M 129.30M 256.90M 282.60M
Total Assets 3.84B 3.49B 3.29B 3.05B 2.93B 2.97B 3.23B 3.19B 3.01B 2.88B 2.79B 2.91B
Total Debt 690.70M 738.30M 741.40M 745.70M 744.40M 739.00M 783.60M 570.30M 545.70M 605.00M 611.30M 603.80M
Cash & Equiv 393.30M 315.50M 199.10M 44.50M 154.20M 287.40M 193.10M 27.00M 56.20M 66.30M 82.00M 70.00M
Book Value 2.23B 1.89B 1.63B 1.40B 1.33B 1.39B 1.45B 1.52B 1.49B 1.20B 1.10B 1.33B
Return on Equity 0.24 0.20 0.11 0.04 -0.04 -0.16 0.00 0.11 0.13 0.04 0.01 0.04
CRS News
Carpenter Technology Declares Quarterly Cash Dividend
Oct 09, 2026 04:00 AM · globenewswire.com
What Makes Carpenter (CRS) a New Buy Stock
Oct 08, 2026 09:01 AM · zacks.com
Is CRS Set to Gain From Growth in Its Specialty Alloys Operations?
Oct 07, 2026 06:51 AM · zacks.com
Carpenter Technology Touts Record Fiscal 2026 Earnings, Capacity Expansion at Annual Meeting
Oct 06, 2026 10:02 AM · marketbeat.com
6,806 Carpenter Technology Corporation $CRS Shares Sold by Tompkins Financial Corp
Oct 05, 2026 11:37 PM · defenseworld.net
Poolbeg secures South Korean cancer immunotherapy-induced CRS patent
Oct 05, 2026 11:17 PM · proactiveinvestors.com
Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell
Oct 05, 2026 11:00 AM · gurufocus.com
AbbVie and Genmab Announce Epcoritamab in Combination with R-CHOP Demonstrates Significant Improvement in Progression-Free Survival versus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell
Oct 05, 2026 11:00 AM · gurufocus.com
Carpenter Technology Announces Conference Call and Webcast
Oct 01, 2026 04:00 AM · globenewswire.com
Carpenter Technology (CRS) is a Top-Ranked Growth Stock: Should You Buy?
Sep 21, 2026 06:46 AM · zacks.com